Literature DB >> 33302851

Exosome Limitations in the Treatment of Inflammatory Diseases.

Daria Skuratovskaia1, Maria Vulf1, Olga Khaziakhmatova1, Vladimir Malashchenko1, Aleksandra Komar1, Egor Shunkin1, Natalia Gazatova1, Larisa Litvinova1.   

Abstract

BACKGROUND: Despite the great interest and numerous studies, there is currently no unified standard describing the sequential manipulation with cells to obtain exosomes for clinical use.The use of exosomes has become an attractive alternative to cell therapy, since the flexible nature of these biological vesicles allows scientists to manipulate their composition to produce the desired exosomes carrying specific drugs, RNA and proteins. This study aimed to analyse scientific literature on the changes in the functional characteristics of exosomes, depending on the method of manipulation, potentially contributing to the development of negative effects in the treatment of diseases of inflammatory genesis.
RESULTS: The choice of isolation method affects the expressed sets of protein markers, nucleic acids and receptors on microparticles. Various surface receptors present on the exosome membrane can be engineered to target lesions. Exosomes from healthy patients help to reduce inflammation, normalize intercellular communication and have anti-fibrotic, antioxidant, and cytoprotective effects. Exosomes can change the microenvironment, but the microenvironment can also change the composition of exosomes.
CONCLUSION: Exosomes obtained from sick patients carry markers characteristic of the corresponding disease. Such exosomes can have pro-inflammatory, pro-fibrotic, cytotoxic, and oncogenic properties, and disrupt cellular cooperation. Until now, questions regarding the dose, reactions to repeated administration, and dosage regimes have not been completely resolved. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Exosomes; MSCs; metabolic disorders; microRNA; therapy.; vesicles

Mesh:

Substances:

Year:  2021        PMID: 33302851     DOI: 10.2174/1381612826666201210120444

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

Review 1.  Skin cell-derived extracellular vesicles: a promising therapeutic strategy for cutaneous injury.

Authors:  Min Wang; Peipei Wu; Jin Huang; Wenhui Liu; Hui Qian; Yaoxiang Sun; Hui Shi
Journal:  Burns Trauma       Date:  2022-10-18

2.  Exosomes Derived From miR-212-5p Overexpressed Human Synovial Mesenchymal Stem Cells Suppress Chondrocyte Degeneration and Inflammation by Targeting ELF3.

Authors:  Tianlei Zheng; Yan Li; Xiaozai Zhang; Jia Xu; Ming Luo
Journal:  Front Bioeng Biotechnol       Date:  2022-02-24

3.  Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.

Authors:  Xuehui Fan; Lukas Cyganek; Katja Nitschke; Stefanie Uhlig; Philipp Nuhn; Karen Bieback; Daniel Duerschmied; Ibrahim El-Battrawy; Xiaobo Zhou; Ibrahim Akin
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

Review 4.  Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications.

Authors:  Yuanwang Jia; Li Yu; Tieliang Ma; Wenrong Xu; Hui Qian; Yaoxiang Sun; Hui Shi
Journal:  Theranostics       Date:  2022-09-06       Impact factor: 11.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.